Publicaciones (31) Publicaciones de María Isabel Álvarez Díaz

2022

  1. The relationships between neuroglial alterations and neuronal changes in Alzheimer’s disease, and the related controversies I: Gliopathogenesis and glioprotection

    Journal of Central Nervous System Disease, Vol. 14

  2. The relationships between neuroglial and neuronal changes in Alzheimer’s disease, and the related controversies II: gliotherapies and multimodal therapy

    Journal of Central Nervous System Disease, Vol. 14

2021

  1. Reflections on cerebellar neuropathology in classical scrapie

    Biomolecules, Vol. 11, Núm. 5

2016

  1. Brain local and regional neuroglial alterations in alzheimer´s disease: Cell types, responses and implications

    Current Alzheimer Research, Vol. 13, Núm. 4, pp. 321-342

  2. Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-Tau accumulation in alzheimer's disease (AD) rodent models: Is fractalkine a systemic biomarker for AD?

    Current Alzheimer Research, Vol. 13, Núm. 4, pp. 403-412

2015

  1. Astroglial cell subtypes in the cerebella of normal adults, elderly adults, and patients with Alzheimer's disease: A histological and immunohistochemical comparison

    GLIA, Vol. 63, Núm. 2, pp. 287-312

2014

  1. Variability in the effects of nicotine on different regions of the brain: Changes in the concentration of superoxide dismutase isoforms

    Central Nervous System Agents in Medicinal Chemistry, Vol. 14, Núm. 1, pp. 10-22

  2. ¿Existe la enfermedad de Alzheimer en todos los primates? Patología Alzheimer en primates no humanos y sus implicaciones fisiopatológicas (II)

    Neurologia

2012

  1. Alzheimer pathology in non-human primates and its pathophysiological implications

    Primates: Classification, Evolution and Behavior (Nova Science Publishers, Inc.), pp. 71-110

  2. Changes induced by natural scrapie in the calretinin-immunopositive cells and fibres of the sheep cerebellar cortex

    Cerebellum

  3. ¿Existe la enfermedad de Alzheimer en todos los primates? Afección de Alzheimer en primates no humanos y sus implicaciones fisiopatológicas (I)

    Neurologia

2011

  1. Lesion-induced vertebrate models of Alzheimer dementia

    Neuromethods, Vol. 48, pp. 295-345

2010

  1. Diversity and variability of the effects of nicotine on different cortical regions of the brain. Therapeutic and toxicological implications

    Central Nervous System Agents in Medicinal Chemistry, Vol. 10, Núm. 3, pp. 180-206

  2. Multiple neuronal and glial mechanisms can be involved in the response to the activation of nicotinic receptors

    Horizons in Neuroscience Research (Nova Science Publishers, Inc.), pp. 225-256

2008

  1. Calretinin-immunopositive cells and fibers in the cerebellar cortex of normal sheep

    Cerebellum, Vol. 7, Núm. 3, pp. 417-429

  2. Immunohistochemical increase in cyclooxygenase-2 without apoptosis in different brain areas of subchronic nicotine- and D-amphetamine-treated rats

    Journal of Neural Transmission, Vol. 115, Núm. 8, pp. 1093-1108

2006

  1. Alteraciones de los fenómenos de neuroplasticidad en las enfermedades de Alzheimer y Creutzfeldt-Jakob. Interrelaciones con fenómenos involutivos

    Mapfre Medicina, Vol. 17, Núm. 4, pp. 236-249

2004

  1. Lesions and dysfunctions of the nucleus basalis as Alzheimer's disease models: general and critical overview and analysis of the long-term changes in several excitotoxic models.

    Current Alzheimer research, Vol. 1, Núm. 3, pp. 189-214

2003

  1. Chronic nicotine administration increases NGF-like immunoreactivity in frontoparietal cerebral cortex

    Journal of Neuroscience Research, Vol. 73, Núm. 5, pp. 708-716

2001

  1. Histochemical study of acute and chronic intraperitoneal nicotine effects on several glycolytic and krebs cycle dehydrogenase activities in the frontoparietal cortex and subcortical nuclei of the rat brain

    Journal of Neuroscience Research, Vol. 64, Núm. 6, pp. 626-635